How I manage aplastic anaemia in children
- 20 February 2012
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 157 (1), 26-40
- https://doi.org/10.1111/j.1365-2141.2012.09058.x
Abstract
Aplastic anaemia (AA) is a rare heterogeneous condition in children. 15-20% of cases are constitutional and correct diagnosis of these inherited causes of AA is important for appropriate management. For idiopathic severe aplastic anaemia, a matched sibling donor (MSD) haematopoietic stem cell transplant (HSCT) is the treatment of choice. If a MSD is not available, the options include immunosuppressive therapy (IST) or unrelated donor HSCT. IST with horse anti-thymocyte globulin (ATG) is superior to rabbit ATG and has good long-term results. In contrast, IST with rabbit ATG has an overall response of only 30-40%. Due to improvements in outcome over the last two decades in matched unrelated donor (MUD) HSCT, results are now similar to that of MSD HSCT. The decision to proceed with IST with ATG or MUD HSCT will depend on the likelihood of finding a MUD and the differing risks and benefits that each therapy provides.This publication has 97 references indexed in Scilit:
- Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenitaGenes & Development, 2011
- Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund–Thomson syndromeHuman Molecular Genetics, 2010
- Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working PartyBritish Journal of Haematology, 2010
- Aplastic Anemia: Pathophysiology and TreatmentTransplantation and Cellular Therapy, 2009
- Shwachman-Diamond Syndrome: A Review of the Clinical Presentation, Molecular Pathogenesis, Diagnosis, and TreatmentHematology/Oncology Clinics of North America, 2009
- Advances in the understanding of dyskeratosis congenitaBritish Journal of Haematology, 2009
- HLA-Matched Sibling Hematopoietic Stem Cell Transplantation for Fanconi Anemia: Comparison of Irradiation and Nonirradiation Containing Conditioning RegimensTransplantation and Cellular Therapy, 2008
- Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemiaBritish Journal of Haematology, 2008
- Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenitaBlood, 2007
- Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemiaBlood, 2007